申请人:The Regents of the University of California
公开号:US20220009891A1
公开(公告)日:2022-01-13
R-aplexone, methods of preparing R-aplexone, or aplexone substantially free of its S-stereoisomer are disclosed. Methods of using R-aplexone or a pharmaceutically acceptable salt or solvate thereof to treat and/or prevent disease are disclosed. Methods of preparing 6-substituted tetrahydropyridine motifs with high enantiomeric excess are also disclosed.
本文披露了制备R-aplexone、制备基本不含其S-立体异构体的aplexone的方法。本文还披露了使用R-aplexone或其药学上可接受的盐或溶剂来治疗和/或预防疾病的方法。本文还披露了制备具有高对映体过量的6-取代四氢吡啶基团的方法。